




This is the author’s final version of the work, as accepted for publication  
following peer review but without the publisher’s layout or pagination.  







Kahn, S., Liao, Y., Du, X., Xu, W., Li, J. and Lönnerdal, B. (2018) Exosomal MicroRNAs in Milk from Mothers Delivering 
Preterm Infants Survive in Vitro Digestion and Are Taken Up by Human Intestinal Cells.  








Copyright: © 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 




Exosomal microRNAs in milk from mothers delivering preterm infants survive 1 
in vitro digestion and are taken up by human intestinal cells 2 
Kahn, Sarah1*; Liao, Yalin2*; Du, Xiaogu1; Xu, Wei2; Li Jie3; Lönnerdal, Bo1. 3 
1. Department of Nutrition, University of California, Davis, 95616, USA 4 
2. School of Veterinary & Life Sciences, Murdoch University, Murdoch WA 6150, 5 
Australia 6 
3. Genome Centre, University of California, Davis, 95616, USA 7 
* equal contribution 8 
 9 
 10 
Address correspondence to: 11 
Dr. Bo Lönnerdal 12 
Department of Nutrition 13 
University of California  14 
Davis CA 95616, USA    15 
Phone: (530) 752-8347 16 
Fax: (530) 752-3564 17 
E-mail: bllonnerdal@ucdavis.edu 18 
 19 
 20 
Key Words: Exosome, Human Milk, Preterm, In vitro Digestion, Intestine, microRNA 21 
 2 
ABSTRACT 22 
Scope: Exosomes are endosomally derived nanovesicles that have been identified in a 23 
number of human body fluids including milk. This study purified milk exosomes from 24 
mothers delivered preterm infants, studied ability of preterm milk exosome to survive 25 
gastric/pancreatic digestion, internalization by intestinal epithelia, and the microRNAs 26 
contained in these exosomes. 27 
Methods and Results: Milk was collected from ten mothers with preterm infants. Samples 28 
were exposed to conditions simulating digestion in preterm infant gut, and exosomes were 29 
isolated. A portion of milk was retained from which exosomes were isolated without 30 
undergoing digestion. Exosomes were lysed and the exposed miRNAs were sequenced. 31 
Exosomes were also collected for in vitro exposure to human intestinal epithelial cells. 32 
Results: Preterm milk exosomes survive in vitro gastric/pancreatic digestion, and can be 33 
taken up by intestinal epithelia. 330 microRNAs were identified as preterm milk exosome 34 
microRNAs, and in vitro digestion does not have pronounced effect on their expression 35 
level. The abundant miRNAs in preterm milk exosome were similar to that of term milk 36 
exosome. 51 microRNAs, which are expressed at low levels, were specifically expressed in 37 
preterm milk exosome compared to term milk counterpart in our previous study [1]. 38 
Conclusion: Our results for the first time reveal the survivability of preterm milk exosome 39 
upon simulated gastric/pancreatic digestion. We also demonstrate the richness of 40 
microRNAs content in these exosomes. The results greatly improve our knowledge of 41 
preterm milk biology and the molecular basis by which preterm infants may uniquely utilize 42 




Human milk provides ideal nutrition for infants providing all required macronutrients for 46 
neonatal growth and development. A wide variety of functional compounds including sIgA, 47 
lactoferrin, lysozyme, oligosaccharides and IGF-I have been shown to influence the 48 
development of the neonatal gut and immune system [2] [3] [4], and much more. 49 
Milk exosome encapsulates various types of nutrients, e.g proteins, mRNAs, miRNAs, 50 
protecting against enzymatic and nonenzymatic degradation of nutrient cargos [5]. Exosome 51 
surface proteins are associated with membrane binding and transport as well as antigen 52 
presentation and they, therefore, have the potential to mediate cell–to-cell communication 53 
among distant cells [6] [7] [8] [9].  54 
Exosomes exert their regulatory effects through a number of mechanisms including 55 
membrane protein signaling and the transfer of RNA material. The size of milk exosome 56 
broadly concurs with exosomes identified in other types of body fluid such as blood, urine, 57 
amniotic fluid [1] [10]. Milk exosomes bear important biological functions, e.g. rat milk-58 
derived exosomes promote IEC-18 cell viability, enhance proliferation, and stimulate 59 
intestinal stem cell activity [11], providing experimental evidence towards explaining why 60 
breast milk administration is beneficial to treat necrotizing enterocolitis. Exosomes with a 61 
high level of TGFβ2 led to epithelial-mesenchymal transition in both cancer and benign 62 
breast cells, consistent with the development and progression of breast cancer [12]. 63 
Human milk is a dynamic fluid changing in composition over the course of a single feeding 64 
as well as over the lactation period [13]. Lactose and lipid content are known to increase 65 
over the immediate postpartum period while the protein content gradually decreases [2]. 66 
Additionally, milk from mothers who delivered preterm infants (conveniently named 67 
 4 
“preterm milk” in this study) is known to differ significantly from those delivering term 68 
infants (conveniently named “term milk” in this study) by containing more protein and lipid, 69 
proportional to the decreasing gestational age of the infant [14] [15]. Unlike macronutrients, 70 
potential differences in exosome content between preterm and term human milk have very 71 
limited information. A recent study on exosome proteome revealed that among the 920 72 
bovine and human milk exosome proteins identified from colostrum and mature milk 73 
samples, 575 were differentially expressed [16]. In our recently published study, we isolated 74 
human milk exosomes from early/mid/late lactating mums delivered term infants, visualized 75 
human milk exosome intestinal epithelial cell uptake, and identified 288 mature microRNAs 76 
[1]. hsa-miR-22-3p was the most abundant miR, and the top 15 microRNAs contributed 77 
~11% of the sequencing reads. Moreover, the overall microRNA abundance in human milk 78 
exosomes was stable upon in vitro simulated gastric/pancreatic digestion. Carney and 79 
colleagues compared the preterm (3-4 weeks postpartum)/term milk (colostrum and 3-4 80 
weeks postpartum) microRNA profile in the lipid and skim compartments, fifteen 81 
microRNAs differ in lipid fraction between term and preterm milk, twelve microRNAs 82 
differ in skim milk between term and preterm milk, and gene targets of these microRNAs 83 
were functionally related to elemental metabolism and lipid biosynthesis [17].   84 
In this study we aim to isolate exosome in milk from mothers delivering preterm infants, 85 
examine the effect of gastric/pancreatic in vitro digestion on small intestinal epithelial 86 
uptake, and analyze the microRNA content in preterm milk exosomes.  87 
 88 
METHODS 89 
Ethics Statement  90 
 5 
Signed consents were obtained from all women participating in this investigation. The study 91 
was approved by the Institutional Review Board of the University of California, Davis 92 
(Permission Number xxxx?).  93 
 94 
Subjects 95 
Ten lactating mothers who had delivered preterm infants were recruited from University of 96 
California Davis Medical Center (UCDMC) neonatal intensive care unit between June and 97 
November of 2014. These mothers delivered preterm infants between 24 and 30 weeks of 98 
gestation (Table 1). All mothers were producing an excess of milk, and their infants were 99 
exclusively fed their own mothers’ milk. Additionally, all mothers were over the age of 18 100 
years, reportedly healthy and without any autoimmune conditions.  101 










Infant age# at 
milk collection 
E* 11 31 24w 3d§ 1w 1d 
E 12 32 25w 1d 2w 1d 
E 13 33 26w 3d 1w 6d 
E 14 34 27w 6d 6d 
V* 15 35 28w 1w 6d 
V 16 36 28w 5d 1w 3d 
V 17 37 29w 1w 2d 
V 18 38 30w 2d 1w 2d 
V 19 39 30w 5d 1w 3d 
E 20 40 27w 5w 3d 
# Chronological age. 103 
*E: extremely preterm (<28w); V: very preterm (28<- <32w). (WHO preterm birth fact 104 
sheet N°363). 105 
§ w: week; d: day. 106 
 107 
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Human Milk Sample Collection 108 
Each mother expressed milk on her usual routine and immediately provided 40 mL of fresh 109 
milk to the study personnel. Breast milk samples were collected into sterile 40 ml tubes by 110 
using breast pump. Collection tubes contained 800 units RNase inhibitor (New England 111 
BioLabs, Ipswich, MA). All samples were immediately frozen on dry ice, and transported to 112 
the laboratory for storage at -80°C until analyses. For mothers delivering preterm infants, 113 
milk was collected at a corrected gestational age between 25 and 32 weeks. All milk 114 
collected was from the early lactation period. 115 
 116 
Human milk exosome isolation and purification 117 
Exosomes were isolated by differential centrifugation of human milk aliquots (20 ml). Low 118 
speed centrifugation at 2,000 x g for 10 min at 4°C was used to remove the fat globule layer. 119 
The defatted milk was transferred to a new tube containing RNase inhibitor, followed by 120 
centrifugation at 12,000 x g for 30 min at 4°C to remove the top fat layer and cellular debris. 121 
The supernatant was filtered through an RNase-free syringe equipped with a 0.45 µm pore 122 
size PVDF sterile filter (Fisher Scientific, Pittsburgh, PA) to further eliminate cells and 123 
cellular debris. The filtered supernatant was incubated with a 5:1 (v/v) ratio of milk: 124 
ExoQuick-TC solution (SBI system Biosciences, Mountain View, CA) for 12 h at 4°C. This 125 
mixed solution was used for subsequent analysis, according to the manufacturer’s 126 
instruction with minor modifications for milk. For Next-generation sequencing (NGS) 127 
analysis, exosomes were processed with a SeraMir Exosome RNA amplification kit (SBI 128 
System Biosciences, MountainView, CA) to prepare RNA libraries. For transmission 129 
electron microscopy (TEM) imaging, SDS-PAGE/Western blot/antibody array, and uptake 130 
assays, exosomes were re-suspended in either 2% PFA in 1xPBS, 1xRIPA buffer containing 131 
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protease inhibitor (Roche, Indianapolis, IN), or exosome binding buffer. Re-suspended milk 132 
exosomes were stored at −80°C when appropriate for further experiments. 133 
 134 
In vitro digestion of human milk exosomes  135 
Samples were thawed and each milk sample was divided into two parts. One remains 136 
untreated by digestive enzymes (which is assigned as “undigested”), and the other part 137 
(which is assigned as “digested”) was exposed to equivalent simulated digestion in preterm 138 
infants. The samples were acidified to pH 4.5 with hydrochloric acid (1M), then adding 139 
porcine pepsin (Sigma, St. Louis, MO) solution at a 1:12.5 enzyme to protein ratio, followed 140 
by incubation at 37°C, 150 rpm, for 20 min in the dark (incubator shaker, New Brunswick 141 
Scientific, Edison, NJ). After in vitro gastric digestion, the pH of the milk was adjusted to 142 
7.0 with NaHCO3 (1M), and pancreatin (0.4% in 0.1M NaHCO3, Sigma) was added at an 143 
enzyme to protein ratio of 1:62.5. Samples were then further incubated in an incubator 144 
shaker at 150 rpm for 30 min at 37°C. Enzymes were inactivated at 85°C for 3 min.  145 
Digested milk exosome RNA and protein were processed as described above. Breast milk 146 
samples without enzyme treatments were analyzed at the same time as control. Exosome 147 
protein concentration was determined by Bradford assay.  Exosome proteins (5 µg/lane) 148 
from undigested and in vitro digested milk samples were boiled for 5 min in Laemmli 149 
sample buffer (Bio-Rad, Hercules, CA) with β-mercaptoethanol (5%). Samples were applied 150 
to 10% sodium dodecyl sulfate−polyacrylamide gel electrophoresis (SDS-PAGE), and 151 
electrophoresed at 200 V for 60 min at 4°C.  Gels were stained in 0.1% Coomassie Brilliant 152 
Blue R-250 (Sigma) for 15 min at RT, and destained in destaining solution (10% acetic acid, 153 
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20% ethanol) for 24 h. Gels were dried with Gel Drying Film (Promaga Corporation, 154 
Madison, WI). 155 
 156 
miRNA Sequencing 157 
 Forty RNA libraries were constructed using the TruSeq Small RNA sample 158 
preparation kit (Illumina, San Diego, CA). Two libraries were created for each lactating 159 
mother; one from the RNA isolated in the undigested sample and the other from the 160 
digested portion of the sample. RNA purity was assessed using the Bioanalyzer 2100 161 
(Agilent Technologies, Santa Clara, CA). Size selection was performed after acceptable 162 
purity was achieved using the Blue Pippin 3% agarose cassette (Sage Science, Beverly 163 
MA). Purity was again assessed after size selection and samples were submitted for ? nt 164 
paired end sequencing using the HiSeq 2500 Ultra-High-Throughput Sequencing System 165 
(Illumina, city, state). 166 
 167 
miRNA Differential Expression Analysis 168 
miRNAs that were present in only one or two samples were excluded prior to 169 
analysis.  Differential expression analyses were conducted using limma-voom [18] (version 170 
3.10.2 of edgeR, version 3.24.5 of limma, in R 3.2.0), using a two-factor model with effects 171 
for term vs. preterm and for digested vs. undigested, and using limma’s generalized least 172 
squares functionality to address within-mother correlation.  Limma-voom was used for 173 
differential expression testing rather than edgeR because this allowed mother to be treated 174 
as a random effect rather than a fixed effect. Heat maps were created using R statistical 175 
software (R Foundation, Boston, MA) to illustrate differentially expressed miRNAs in the 176 
undigested and digested term and preterm groups. When comparing miRNA expression 177 
among the groups an adjusted p-value of <0.05 was used to determine significance. 178 
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 179 
Cell Culture  180 
Non-transformed human intestinal epithelial crypt-like cells (HIEC) (kind gift from Dr. 181 
Jean-Francois Beaulieu, Université de Sherbrooke) [19], were cultured in Opti-MEM (Life 182 
Technologies Inc Gaithersburg, MD) medium, supplemented with 20 mM HEPES (Thermo 183 
Fisher Scientific), 10 mM GlutaMAX (ThermoFisher Scientific), 10 ng/mL EGF (Thermo 184 
Fisher Scientific), 5% fetal bovine serum (FBS, MP Biomedicals, Santa Ana, CA).  Prior to 185 
use, microvesicles in FBS were precipitated with ExoQuick-TC (5:1, v/v) at room 186 
temperature for 2 h, followed by centrifugation at 3000 x g for 30 min, and the supernatant 187 
was used as FBS in this study. The cells were cultured in a humidified incubator (Forma 188 
Series II Water jacketed CO2, Thermo Electron Corporation, Madison, WI) at 37°C under 5% 189 
CO2. Cells between passages 18–23 (Tina’s file sent on Oct 3 use 5-10 passages, which is 190 
correct?) were used and medium was changed every other day. 191 
 192 
Immunoblotting 193 
Protein samples 20µg were separated by SDS-PAGE (10% gel) and transferred onto a 194 
nitrocellulose membrane. The membrane was incubated in blocking buffer (5% bovine 195 
serum albumin in 1x phosphate-buffered saline Tween-20 (PBST)) for 60 min at room 196 
temperature, washed three times with PBST, and then probed with primary antibodies of 197 
CD54, Lactoferrin, Golgi marker GM130 at 1: 1,000 dilution (in PBST), for 60 min at room 198 
temperature. After three washes with PBST, the membrane was incubated with horseradish-199 
peroxidase-conjugated donkey anti-rabbit IgG (1:20,000) in blocking buffer for 45 min at 200 
room temperature. The membrane was washed before signals were visualized with ECL 201 




Isolated milk exosome were resuspened in 1xPBS and centrifuged at 12,000 x g for 20min. 205 
Exosome lysis buffer (SBI system Biosciences) was added into exosome pellet, and vortex 206 
for 15 seconds.  Lysis mixture were placed at room temperature for 5 minutes to allow 207 
complete lysis (in our published paper, the exosomes were in vitro digested before treating 208 
the cells, not lysed, which is what was done? This is in published paper methods: The cells 209 
were then treated at 37 °C with 200 µg exosome proteins which had been digested in vitro at 210 
either pH 2.0 or pH 4.0, and subsequently fixed,).  HIEC were seeded and grown on 24-well 211 
plate with round sharp coverslip for 2 days to reach xxx% confluency. Treat cells with 212 
exosome procedure should be added here. Cells were incubated with exosome marker 213 
protein CD9 (Santa Cruz) antibody in serum-free medium for 30 min at 37 °C, cells were 214 
rinsed with PBS, fixed with 4% phosphate-buffered paraformaldehyde (0.4 mL/well) for 10 215 
min at room temperature, and then permeabilized with Triton X-100 (0.2%) in PBS for 10 216 
min at room temperature. Cells were subsequently blocked with blocking buffer (5% heat 217 
inactivated rabbit serum and 1% BSA in PBS, 0.5 mL/well) for 20 min. After the blocking 218 
buffer was removed, cells were rinsed with PBS. Cell was probed with Alexa 488-219 
conjugated-anti-rabbit IgG in blocking buffer for 45 min. The nucleus was stained with 220 
TOPO-3 1:1,000 in blocking buffer (Invitrogen Molecular Probes) for 30 min. After several 221 
rinses, coverslips were mounted with a ProLong Gold antifade reagent (Invitrogen 222 
Molecular Probes) and sealed with nail polish. A confocal laser scanning microscope 223 
(FV1000, Olympus America, Inc., Melville, New York, USA) was used to perform 224 
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immunofluorescence imaging, and image analysis by using the accompanied software from 225 
Olympus America, Inc.  226 
 227 
RESULTS 228 
Quality of Human Milk Exosome miRNA Sequencing Data 229 
 20 microRNA sequencing libraries were generated, which were composed of 230 
undigested and digested milk sample pairs from ten lactating mothers. Total raw sequencing 231 
reads and mapping efficiency are shown in Supplemental Table 1. Each small RNA library 232 
generated between 0.57 and 7.49 million reads and 898 discreet mature miRNA sequences 233 
were obtained. As expected, the lowest number of reads correlated with a lower amount of 234 
source material. All samples were assessed for quality and were given a quality score prior 235 
to analysis. All samples had a quality score greater than 30 which corresponds to an error 236 
probability of less than 1 in 10, and in all cases the percent of perfect reads was 94.5% or 237 
better.  238 
 239 
Preterm Human Milk Exosome Survives Simulated in vitro Digestion and Enters Small 240 
Intestinal Epithelia 241 
The experimental setup is shown in Figure 1A, each of the 10 Preterm milk samples were 242 
aliquoted to 2 parts, one serves as control, and the other was subjected to in vitro simulated 243 
gastric/pancreatic digestion. In our previous study of exosomes isolated from term milk, the 244 
pH was adjusted to 4.0 [1], in the current study however, we used slightly less acidic pH4.5 245 
to simulate Preterm infant gastric environment based on pH evaluation of the preterm 246 
infant’s stomach following feeds [20]. The exosome protein profile was visualized by SDS-247 
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PAGE. Coomassie brilliant blue stain data between term and preterm milk are similar, major 248 
proteins are at approximately 75KDa and 25KDa in each individual sample. In digested 249 
samples, the size distance between group 1 and group 2 proteins are larger in digested 250 
samples, whereas that between group 3 and group 4 proteins become smaller. This 251 
suggested that the susceptibilities of different major protein groups to digestion vary, e.g. 252 
transmembrane proteins on exosome surface may respond to proteolytic enzyme more 253 
readily than proteins fully enclosed. We next examined the exosome surface marker 254 
expression, CD54 (ICAM-1) is intact in the investigated samples even after in vitro 255 
digestion [1] (Figure 1C). In one of the term milk (Term 2), level of CD54 has a decent 256 
expression shown in digested sample (Figure 1C, lane 6 from left), we therefore are 257 
confident that it is also present in the undigested counterpart, the rather faint band in the 258 
immunoblotting (Figure 1C, lane 2 from left) may be due to large contrast among bands on 259 
the same blot, and therefore short exposure time to prevent saturation of certain lanes. 260 
Detection of both CD54 and Lactoferrin in milk exosome is specific as they are not shown 261 
in control Ramos cells, but golgi marker GM130 is only detected in the control. 262 
Furthermore, confocal microscope showed internalization of exosomes by HIEC cells, and 263 
nuclear localization can also be seen. In summary, these biochemical analyses suggest that 264 
human Preterm milk exosomes survives simulated in vitro digestion mimicking Preterm 265 
infants, and uptake by intestinal epithelial cells also agree with what we found in term milk 266 
exosome [1]. 267 
 268 
Comprehensive Identification of Human Preterm Milk Exosome microRNAs 269 
Various compartments of human milk, e.g. cells, MFGM, lipid contain microRNAs [21] [22]. We 270 
then analyzed microRNAs profile in preterm human milk, and studied how the microRNAs 271 
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respond to in vitro digestion. To this end, 20 microRNA sequencing libraries were generated, 272 
which were composed of undigested and digested Preterm milk sample pairs from 10 mothers. 273 
Mapping efficiency is shown in Supplemental Table 1. We used the same approach as in our 274 
recent term milk exosome microRNA study which had 24 libraries [1], ranked the relative 275 
abundance of all the detected microRNAs by the summed normalized read counts (counts-per-276 
million) of all 20 libraries (Figure 2A), and there were 447 microRNAs with scores less than 20 277 
reads, 118 microRNAs with scores between 20 and 40 reads. 330 microRNAs had normalized 278 
total read counts more than 40, and were therefore assigned as preterm milk exosome microRNAs 279 
(Supplemental Table 2).  280 
We first compared the 330 microRNAs with the 32 microRNAs recently identified from preterm 281 
milk skim compartment by Carney and colleagues [17], there are 13 common ones between these 282 
two datasets, hsa-miR-378g, hsa-miR-378a-3p, hsa-miR-1260a, hsa-miR-1260b, hsa-miR-378c, 283 
hsa-miR-7704, hsa-miR-4454, hsa-miR-378i, hsa-miR-7641, hsa-miR-375, hsa-miR-378a-5p, 284 
hsa-miR-423-3p, and hsa-miR-320a. 285 
Half of the preterm exosome microRNAs have 40-110 normalized counts, whereas the other half 286 
of the microRNAs span a wider counts distribution from 110 to more than 300 (Figure 2B). 287 
Similar to what we observed in term milk exosome microRNA [1], the top 15 abundant 288 
microRNAs represent ~10% of total reads (Figure 2C, bar graph). Half of the normalized 289 
sequencing reads are contributed by 95 (28.8%) of all the 330 microRNAs (Figure 2C, bar graph). 290 
The identity of top 15 abundant microRNAs in Preterm and term human milk exosome also 291 
largely agree (Figure 2C, enlarged bar with detailed identity of top 15 microRNAs), e.g. hsa-miR-292 
22a-3p is the most abundant microRNA species. The following top 15 miR of preterm milk 293 
exosome miR are not in the top 15 of term milk exosome miR, hsa-320a, hsa-378a-3p, hsa-99b-294 
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5p, hsa-146b-5p, and hsa-1307-5p, however, hsa-320a, hsa-378a-3p, hsa-99b-5p, hsa-146b-5p are 295 
still among the abundant ones, ranking within top 25. Normalized hsa-1307-5p reads are similar 296 
in control and digested samples. It only ranked 41st in term milk exosome (among 288 297 
microRNAs identified, 0.57% of total counts), and ranked 15th in term milk (among 330 298 
microRNAs identified, 0.65% of total counts), its function is largely unknown as it was first 299 
believed that only 3p of this microRNA exist. hsa-1307-5p is expressed in gastric tissue[23], and 300 
is one of the differentially expressed microRNAs in PCOS compared to control, it may be 301 
involved in important cellular processes, such as Notch signaling, hormone and energy 302 
metabolism [24]. Our result of increased ranking and abundance in Preterm exosome of hsa-1307-303 
5p suggests a novel role that it may play in early gastric development, particularly in Preterm 304 
infans. 305 
 306 
Preterm Specific microRNAs are Mostly of Low Abundance 307 
The overlap of exosome microRNAs in term and Preterm milk were compared, and we did in two 308 
levels. First, among the top 200 microRNAs in Preterm milk exosome, 199 are also present in that 309 
of term milk; Second, when the rest of the low abundant 130 microRNAs are included, the 310 
number of Preterm milk exosome specific microRNAs increased to 51, suggesting preterm milk 311 
exosome microRNAs profile differ from mature counterpart mainly in their low abundant species. 312 
We then further analyzed these 51 preterm milk exosome specific microRNAs (compared to term 313 
milk exosome), by examining the effect of in vitro digestion on their relative abundance. Based 314 
on WHO clinical classification of preterm birth (WHO preterm birth fact sheet N°363, 315 
http://www.who.int/mediacentre/factsheets/fs363/en/), the participants in our study were grouped 316 
into very preterm (Table 1, 5 subjects) and extremely preterm (Table 1, 5 subjects) when 317 
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considering the effect of in vitro digestion. All 51 preterm milk exosome specific microRNAs 318 
(15.45% of all preterm milk exosome microRNAs) account 7.07% of all normalized sequencing 319 
reads. As shown in Figure 3C, in vitro digestion had widespread influence on the relative 320 
abundance of these microRNAs. In extremely preterm group, in vitro digestion increased 321 
abundance in 17 microRNAs, whereas in very preterm group, it increased abundance in 35 322 
microRNAs, including 12 that were also increased in extremely preterm group; comparing 323 
extremely- and very- preterm groups, more than half (29) of these preterm specific microRNAs 324 
are regulated in opposite direction by in vitro digestion (detailed calculation in Supplemental 325 
Table 3).  326 
 327 
In Vitro Digestion Does Not Have Pronounced Effect Among Abundant Preterm 328 
Exosome microRNAs  329 
Having looked at low abundant preterm specific milk exosome microRNAs, we also 330 
attempted similar analysis on abundant microRNAs. Figure 4 shows data of the top 15 331 
abundant ones, and the full presentation of data is in Supplemental Table 2. Shown in Figure 332 
4A, in extremely preterm group, 9 microRNAs had average abundance change of no more 333 
than 5% responding to in vitro digestion, abundance of the other 6 microRNAs all increased 334 
by more than 5%, albeit the highest being 8.76%. In very preterm group, 8 microRNAs had 335 
average abundance change of no more than 5% responding to in vitro digestion, For the 336 
other 7 microRNAs, 6 were increased (3 of them by more than 10%, highest being 16.15%), 337 
and 1 was decreased by 6.39%. Overall, in vitro digestion does not have pronounced effect 338 
among these abundant preterm exosome microRNAs, although the effect is subtly stronger 339 
in very preterm group compared to extremely preterm group. 340 
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Inter-individual variation is a remarkable characteristic for human milk nutrient components 341 
[25] [1] [26], here we also explored this aspect in preterm milk abundant microRNAs, 342 
similar to what was mentioned earlier, the full presentation of data is in Supplemental Table 343 
2. Figure 4B illustrates in detail the normalized counts of top 15 abundant microRNAs in 344 
each of the twenty sequencing libraries, for most of the microRNAs (11 for extremely 345 
preterm group, 14 for very preterm group), standard deviation of abundance is lower in 346 
digested samples compared to their undigested counterparts, the average reduction in 347 
extremely preterm group is 47.75%, and 71.95% in very preterm group. Our data in Figure 348 
4B therefore suggests that in vitro digestion reduce the inter individual variation of abundant 349 
preterm milk microRNAs. 350 
 351 
DISCUSSION 352 
In this study, we isolated exosomes from mothers who delivered preterm infants, the 353 
exosomes underwent simulated in vitro digestion mimicking the gut environment of preterm 354 
infants. We examined the uptake of these exosomes via intestinal epithelia, we also 355 
performed deep sequencing on the microRNAs in these exosomes, comparing mainly to the 356 
exosome microRNAs from mothers who delivered term infants [1] our group recently 357 
published using the same analysis criteria. We found that preterm milk exosomes can be 358 
internalized by intestinal epithelial cells and locate to the nucleus. Milk exosomes of 359 
mothers delivering term and preterm infants contain similar miRNAs, and preterm specific 360 
microRNAs are mostly of low abundance. 361 
Unlike free RNA which is susceptible for degradation, our results confirm previous studies 362 
that demonstrate exosomal RNA can be recovered even from milk exposed to harsh 363 
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conditions simulating digestion in the gut, e.g. Izumi and colleagues successfully recovered 364 
exosomal miRNA from milk acidified to pH as low as 2 as well as milk treated with RNase 365 
and detergents [27]. In our study, miRNA was isolated from all preterm milk samples even 366 
after milk was exposed to acidification and digestive enzymes suggesting that the exosome 367 
miRNAs remain intact in infant’s intestine. Our data confirm preterm milk exosomes 368 
internalization to the intestinal epethelia, cargos of these exosomes may exert function 369 
locally in the gut, but also may enter circulation, e.g. in adults, miRNA from bovine milk 370 
has been shown to enter the plasma, and nutritionally relevant concentrations of bovine 371 
miRNA affect immune cells in culture [28].  372 
Florescence microscopy of the labeled human milk exosomes shows that human intestinal 373 
epithelial cells have the ability to take up human milk exosomal RNA and protein in vitro. 374 
Our results are in agreement with our recent study showing similar results for term milk 375 
exosome [1] and previous investigations of bovine milk exosomes demonstrating uptake by 376 
endocytosis in cell lines [29]. Mother’s milk exosome may join the pool of intestinal 377 
exosomes, known to play a role in the mucosal response to pathogens [30, 31]. In addition, 378 
miRNAs contained in the exosomes may in particular strengthen direct effect on the 379 
intestinal mucosa, safeguarding intestinal permeability and barrier function [32]. 380 
The miRNAs in preterm milk exosomes were similar across all samples (Supplemental 381 
Table 2), suggesting that the expression of milk exosome miRNA is not random, and that 382 
miRNA content in the exosome is largely protected, likely by encapsulation. Additionally, 383 
previous studies on cow milk have shown that the miRNAs in milk exosomes do not seem 384 
to simply reflect those of the mammary gland or serum [33], instead microRNA 385 
composition cater for infant need, in our study, many of the miRNAs recovered from both 386 
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term and preterm milk are associated with inflammation and immune system regulation as 387 
well as cell growth and development [1]. The most highly expressed miRNA across all four 388 
groups, for example, is miR-22-3p. miR-22-3p is known to be ubiquitously expressed in 389 
mammals and is associated with stem cell differentiation in a number of human tissues 390 
including cardiac and adipose tissues [34].  In dendritic cells, miR-22-3p has been shown to 391 
affect production of IL-6 which plays a significant role not only in the response to 392 
pathogens but also in the development of auto-immune disease [35]. Similarly, miR-148a-393 
3p, which was also highly expressed in preterm milk exosome, is associated with decreasing 394 
the inflammatory response of cardiac tissue, as well as having a role in the differentiation of 395 
embryonic cells [36] [37]. The miR-30 family of which several members are highly 396 
expressed in human milk has also been previously shown to play a role in cellular 397 
proliferation and differentiation [38] [39]. After birth, the infant gut is exposed for the first 398 
time to both pathogenic and commensal bacteria, and it is possible that milk miRNAs aid 399 
the infant gut both in developing its defenses against pathogens while maintaining self-400 
tolerance [40]. One previously studied miRNA is miR-146a, which was present in both 401 
preterm and term milk, and has been shown to blunt hypoxic/reperfusion injury in intestinal 402 
epithelial cells [41] [42]. 403 
A related recent study by Carney and colleagues studied lipid and skim compartments [17], 404 
identifying 32 microRNAs in skim fraction, which includes exosome as indicated by the 405 
methods used. Our study identified approximately ten times (330) microRNAs in preterm 406 
milk exosome. The common microRNAs between these two datasets are analyzed in the 407 
Results section. Half of the subjects in our current study are extremely preterm as early 24 408 
weeks 3 days, and the other half are very preterm subjects, with the highest gestational age 409 
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at 30 weeks 5 day, whereas all Carney et al. study subjects have gestational age between 29 410 
and 35 weeks, which cover very preterm and preterm groups, we speculate that the degree 411 
of prematurity may have an effect on the microRNA expression profile; Most of samples in 412 
our current study were collected when the prematurely born infants are between one week 413 
and two week of age (Table 1), Carney and colleagues collected sample mostly when the 414 
infants are 3 to 4 weeks old, it is likely that preterm exosome microRNA also has 415 
longitudinal change over lactation. 416 
We also compared this 330 preterm milk exosome microRNA profile with our recently 417 
published term milk exosome microRNA data [1], analyzed by the same criteria. As we 418 
have ten subjects for the preterm exosome microRNA dataset and twelve subjects for the 419 
term dataset, we only qualitatively compared them showing 51 are specifically identified in 420 
preterm milk exosome, whereas only 9 are specifically in term milk exosome. Nevertheless, 421 
it is an interesting finding that these 51 exosomes are expressed at low abundance in each 422 
individual samples, suggesting that the more abundant exosome microRNAs in human milk 423 
(both term and preterm) may be involved in housekeeping functions, and preterm milk 424 
exosomes express more number of regulatory microRNAs that cater the needs for preemies. 425 
In keeping with previous studies, this study demonstrates that preterm human milk 426 
exosomes contain miRNAs that survive even after exposure to in vitro digestion mimicking 427 
preterm infants gut. Consequently, exosomal miRNAs may exert regulatory effects. 428 
Abundant miRNAs obtained from the milk of mothers delivering term and preterm infants 429 
remain similar. Although many miRNAs have been studied in relation to their expression in 430 
a malignant state, their role in the developing infant gut remains largely unknown. Future 431 
studies regarding the effect of human milk exosomes on growth, development and immune 432 
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response of intestinal cells are needed. Inflammation, especially within the preterm gut, is a 433 
significant cause of morbidity in the neonatal population in the form of necrotizing 434 
enterocolitis. The possibility that certain miRNAs may help diminish the inflammatory 435 
process may allow the development of future therapies. Additionally, future studies are 436 
needed regarding the ultimate targets of human milk miRNAs, especially as the uptake of 437 
miRNAs by intestinal epithelial cells suggests that the exosomal miRNAs may be passed 438 
from the mother’s mammary gland to the infant serum, regulating not only the development 439 
of the infant gut but also the development of infant cells far from the intestinal lumen. Last 440 
but not least, since infant formulas contain very few miRNAs compared to whole human 441 
milk [22], the presence of miRNAs in human milk exosomes may be responsible for some 442 
of the differences in outcomes between breast-fed and formula-fed infants. 443 
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FIGURE LEGENDS 551 
Figure 1.  Characterization and uptake of preterm milk exosome.  552 
A. experimental flow of the study.  553 
B. Proteins (5 μg/lane) from exosomes were digested with pepsin at pH 4.5 followed by 554 
pancreatin digestion (see details in Methods), subjected to SDS-PAGE, and stained with 0.25% 555 
Coomassie brilliant Blue R-250.  556 
C. Proteins from term and preterm human milk exosome were resolved by SDS-PAGE, and 557 
analyzed by western blot. Ramos cell lysate was used as a positive control in CD54 and 558 
Lactoferrin western; Caco-2 cell lysate was used as positive control in GM130 western. 559 
D. Representative confocal images of the localization of digested human milk exosomes 560 
following incubation with HIEC cells. Cells were viewed at 60✕ magnification. Green (Alexa 561 
Fluor 488), exosome; red (Topro3-iodide), nuclei. Scale bar, 20 μm. 562 
 563 
Figure 2. Global characterization of preterm milk exosome microRNAs. A. Pie chart of 564 
microRNAs detected at varying abundance. B. Distribution of microRNAs based on their 565 
normalized counts. C. Top 15 preterm milk exosome microRNAs. D. Comparison of 566 
preterm milk exosome microRNAs with those in term milk (Liao et al. 2017). 567 
 568 
Figure 3. mature microRNAs identified only in preterm milk exosome. A. Pie chart of 569 
preterm milk exosome microRNAs compared to term milk exosome [1]. Left, top 200 570 
preterm exosome milk exosome microRNAs; Right, all 330 preterm exosome milk exosome 571 
 24 
microRNAs. B. Heatmap visualizing preterm milk exosome specific microRNAs expression 572 
upon in vitro digestion. microRNA expression is calculated as average of all five samples in 573 
each group (Extremely preterm-U, Extremely preterm-D, Very preterm-U, Very preterm-D). 574 
U indicates undigested, D indicates in vitro digested. 575 
 576 
Figure 4. Heat map visualizing the top 15 microRNAs in preterm milk exosome upon in 577 
vitro digestion.  A. microRNA expression is calculated as average of all five samples in 578 
each group (Extremely preterm-U, Extremely preterm-D, Very preterm-U, Very preterm-D). 579 
B. microRNA expression is presented as individual values of each sample. U indicates 580 
undigested, D indicates in vitro digested. 581 
 582 
Table 1. Gestational age at delivery and milk collection schedule. 583 
 584 
Supplemental Table 1. Summary of sequencing reads. (see our Mol Nutr Food Res paper 585 
supplemental table 1. Currently not available for this preterm manuscript.) 586 
Supplemental Table 2. Normalized microRNA sequencing counts of all identified 587 
microRNAs. 588 











Infant age# at 
milk collection 
E* 11 31 24w 3d§ 1w 1d 
E 12 32 25w 1d 2w 1d 
E 13 33 26w 3d 1w 6d 
E 14 34 27w 6d 6d 
V* 15 35 28w 1w 6d 
V 16 36 28w 5d 1w 3d 
V 17 37 29w 1w 2d 
V 18 38 30w 2d 1w 2d 
V 19 39 30w 5d 1w 3d 
E 20 40 27w 5w 3d 
# Chronological age. 
*E: extremely preterm (<28w); V: very preterm (28<- <32w). (WHO preterm birth 
fact sheet N°363). 
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